Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanistic, preclinical, and preliminary clinical studies.
PubMed 21516129 · doi:10.1038/onc.2011.91
What was done
This is a narrative review comparing the cellular protective mechanisms and therapeutic potential of acute fasting (zero caloric intake) versus long-term dietary restriction (20% to 40% caloric reduction) across simple model organisms, rodents, and preliminary human clinical reports in the context of cancer chemotherapy.
What was found
In mammals, fasting causes an over 50% reduction in circulating glucose and insulin-like growth factor 1 (IGF-1) levels, triggering protective signaling pathways (differential stress resistance) that oncogene-bearing cancer cells fail to activate. Preliminary clinical reports note that fasting for up to 5 days followed by normal feeding may protect human patients against chemotherapy toxicity without causing chronic weight loss. By contrast, chronic dietary restriction requires weeks to months to take effect, induces more modest glucose and IGF-1 reductions, and leads to sustained weight loss in both rodents and humans. Quantitative human trial data were not detailed in the abstract.
Why it matters
It highlights short-term fasting as a distinct, actionable metabolic strategy to enhance chemotherapy tolerability and differential cellular protection without the chronic wasting associated with long-term caloric restriction.
Limits
This is a narrative review rather than a systematic review or meta-analysis. The human findings mentioned are preliminary, and the abstract lacks quantitative clinical efficacy data, safety metrics, patient characteristics, and sample sizes.
Cited by
- supports Under starvation conditions, normal cells enter a protected mode resistant to chemotherapy toxins, whereas cancer cells carrying oncogenes fail to activate this protective response (differential stress resistance).